YWHAQ expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.130800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.015400E-01
Normal-vs-Stage2
5.471400E-01
Normal-vs-Stage3
4.071400E-01
Normal-vs-Stage4
9.965600E-01
Stage1-vs-Stage2
7.912400E-01
Stage1-vs-Stage3
6.989800E-01
Stage1-vs-Stage4
3.832200E-01
Stage2-vs-Stage3
4.837400E-01
Stage2-vs-Stage4
4.821200E-01
Stage3-vs-Stage4
2.732400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.364800E-01
Normal-vs-AfricanAmerican
9.828200E-01
Normal-vs-Asian
2.715600E-01
Caucasian-vs-AfricanAmerican
4.844800E-01
Caucasian-vs-Asian
2.034400E-01
AfricanAmerican-vs-Asian
1.656950E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.781200E-01
Normal-vs-Female
6.845400E-01
Male-vs-Female
3.630200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.624800E-01
Normal-vs-Age(41-60Yrs)
8.604600E-01
Normal-vs-Age(61-80Yrs)
4.265400E-01
Normal-vs-Age(81-100Yrs)
6.411000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.106040E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.604800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.778800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.217700E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.721200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.623000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.388400E-01
Normal-vs-Daily Drinker
4.697400E-01
Normal-vs-Weekly Drinker
4.116200E-01
Normal-vs-Occasional Drinker
9.277000E-01
Normal-vs-Social Drinker
7.825000E-01
Non Drinker-vs-Daily Drinker
7.666000E-01
Non Drinker-vs-Weekly Drinker
8.439200E-01
Non Drinker-vs-Occasional Drinker
5.268200E-02
Non Drinker-vs-Social Drinker
2.477800E-01
Daily Drinker-vs-Weekly Drinker
9.461200E-01
Daily Drinker-vs-Occasional Drinker
1.368050E-01
Daily Drinker-vs-Social Drinker
4.283800E-01
Weekly Drinker-vs-Occasional Drinker
1.544800E-01
Weekly Drinker-vs-Social Drinker
4.151400E-01
Occasional Drinker-vs-Social Drinker
5.269400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.589200E-01
Normal-vs-Grade 2
6.318800E-01
Normal-vs-Grade 3
1.313620E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.508000E-01
Grade 1-vs-Grade 3
2.537000E-01
Grade 1-vs-Grade 4
3.589200E-01
Grade 2-vs-Grade 3
3.685200E-01
Grade 2-vs-Grade 4
6.318800E-01
Grade 3-vs-Grade 4
1.313620E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.850000E-01
Normal-vs-NonDiabetic
6.072200E-01
Diabetic-vs-NonDiabetic
3.601000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.050800E-01
Normal-vs-NoPancreatitis
6.118000E-01
Pancreatitis-vs-NoPancreatitis
6.941000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.105200E-01
Normal-vs-N1
5.986400E-01
N0-vs-N1
6.971400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
8.048600E-01
Normal-vs-TP53-NonMutant
5.268400E-01
TP53-Mutant-vs-TP53-NonMutant
1.692820E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
